ID: ALA105667

Max Phase: Preclinical

Molecular Formula: C18H36N2

Molecular Weight: 280.50

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCN1CCCC(C2CCCN2C)C1

Standard InChI:  InChI=1S/C18H36N2/c1-3-4-5-6-7-8-14-20-15-9-11-17(16-20)18-12-10-13-19(18)2/h17-18H,3-16H2,1-2H3

Standard InChI Key:  PNOYADQUASQUET-UHFFFAOYSA-N

Associated Targets(non-human)

Creatine transporter 104 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 280.50Molecular Weight (Monoisotopic): 280.2878AlogP: 4.15#Rotatable Bonds: 8
Polar Surface Area: 6.48Molecular Species: BASEHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.43CX LogP: 4.29CX LogD: 0.54
Aromatic Rings: 0Heavy Atoms: 20QED Weighted: 0.62Np Likeness Score: -0.18

References

1. Geldenhuys WJ, Lockman PR, McAfee JH, Fitzpatrick KT, Van der Schyf CJ, Allen DD..  (2004)  Molecular modeling studies on the active binding site of the blood-brain barrier choline transporter.,  14  (12): [PMID:15149650] [10.1016/j.bmcl.2004.04.020]

Source